Search

Zhang, Yang, Tuan M Nguyen, Xiao-Ou Zhang, Limei Wang, Tin Phan, John G Clohessy, and Pier Paolo Pandolfi. 2021. “Optimized RNA-Targeting CRISPR/Cas13d Technology Outperforms ShRNA in Identifying Functional CircRNAs.”. Genome Biology 22 (1): 41.

Mugoni, Vera, Riccardo Panella, Giulia Cheloni, Ming Chen, Olga Pozdnyakova, Dina Stroopinsky, Jlenia Guarnerio, et al. 2019. “Vulnerabilities in MIDH2 AML Confer Sensitivity to APL-Like Targeted Combination Therapy.”. Cell Research 29 (6): 446-59.

Chen, Ming, Lixin Wan, Jiangwen Zhang, Jinfang Zhang, Lourdes Mendez, John G Clohessy, Kelsey Berry, et al. 2018. “Deregulated PP1α Phosphatase Activity towards MAPK Activation Is Antagonized by a Tumor Suppressive Failsafe Mechanism.”. Nature Communications 9 (1): 159.

Tan, Justin L, Rachel D Fogley, Ryan A Flynn, Julien Ablain, Song Yang, Violaine Saint-André, Zi Peng Fan, et al. 2016. “Stress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress Melanoma.”. Molecular Cell 62 (1): 34-46.

Clohessy, John G, and Pier Paolo Pandolfi. 2015. “Mouse Hospital and Co-Clinical Trial Project–from Bench to Bedside.”. Nature Reviews. Clinical Oncology 12 (8): 491-8.

Lunardi, Andrea, Kaitlyn A Webster, Antonella Papa, Bhavik Padmani, John G Clohessy, Roderick T Bronson, and Pier Paolo Pandolfi. 2014. “Role of Aberrant PI3K Pathway Activation in Gallbladder Tumorigenesis.”. Oncotarget 5 (4): 894-900.

Clohessy, John G, and Elisa de Stanchina. 2013. “Infrastructure Needs for Translational Integration of Mouse and Human Trials.”. Cold Spring Harbor Protocols 2013 (12): 1109-14.

Lunardi, Andrea, Ugo Ala, Mirjam T Epping, Leonardo Salmena, John G Clohessy, Kaitlyn A Webster, Guocan Wang, et al. 2013. “A Co-Clinical Approach Identifies Mechanisms and Potential Therapies for Androgen Deprivation Resistance in Prostate Cancer.”. Nature Genetics 45 (7): 747-55.

Alimonti, Andrea, Caterina Nardella, Zhenbang Chen, John G Clohessy, Arkaitz Carracedo, Lloyd C Trotman, Ke Cheng, et al. 2010. “A Novel Type of Cellular Senescence That Can Be Enhanced in Mouse Models and Human Tumor Xenografts to Suppress Prostate Tumorigenesis.”. The Journal of Clinical Investigation 120 (3): 681-93.